# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-21-029613
Filing Date
2021-03-01
Accepted
2021-03-01 07:00:38
Documents
44
Period of Report
2021-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm218241d1_8k.htm iXBRL | 8-K | 26481
2 | EXHIBIT 99.1 | tm218241d1_ex99-1.htm | EX-99.1 | 122096
3 | EXHIBIT 99.2 | tm218241d1_ex99-2.htm | EX-99.2 | 56824
7 | GRAPHIC | tm218241d1_ex99-1img01.jpg | GRAPHIC | 7319
8 | GRAPHIC | tm218241d1_ex99-2img001.jpg | GRAPHIC | 326464
9 | GRAPHIC | tm218241d1_ex99-2img002.jpg | GRAPHIC | 572242
10 | GRAPHIC | tm218241d1_ex99-2img003.jpg | GRAPHIC | 497453
11 | GRAPHIC | tm218241d1_ex99-2img004.jpg | GRAPHIC | 419049
12 | GRAPHIC | tm218241d1_ex99-2img005.jpg | GRAPHIC | 445049
13 | GRAPHIC | tm218241d1_ex99-2img006.jpg | GRAPHIC | 305553
14 | GRAPHIC | tm218241d1_ex99-2img007.jpg | GRAPHIC | 366224
15 | GRAPHIC | tm218241d1_ex99-2img008.jpg | GRAPHIC | 179480
16 | GRAPHIC | tm218241d1_ex99-2img009.jpg | GRAPHIC | 526009
17 | GRAPHIC | tm218241d1_ex99-2img010.jpg | GRAPHIC | 251222
18 | GRAPHIC | tm218241d1_ex99-2img011.jpg | GRAPHIC | 390345
19 | GRAPHIC | tm218241d1_ex99-2img012.jpg | GRAPHIC | 302583
20 | GRAPHIC | tm218241d1_ex99-2img013.jpg | GRAPHIC | 306589
21 | GRAPHIC | tm218241d1_ex99-2img014.jpg | GRAPHIC | 339181
22 | GRAPHIC | tm218241d1_ex99-2img015.jpg | GRAPHIC | 387670
23 | GRAPHIC | tm218241d1_ex99-2img016.jpg | GRAPHIC | 343679
24 | GRAPHIC | tm218241d1_ex99-2img017.jpg | GRAPHIC | 338951
25 | GRAPHIC | tm218241d1_ex99-2img018.jpg | GRAPHIC | 240865
26 | GRAPHIC | tm218241d1_ex99-2img019.jpg | GRAPHIC | 325890
27 | GRAPHIC | tm218241d1_ex99-2img020.jpg | GRAPHIC | 262995
28 | GRAPHIC | tm218241d1_ex99-2img021.jpg | GRAPHIC | 274439
29 | GRAPHIC | tm218241d1_ex99-2img022.jpg | GRAPHIC | 355785
30 | GRAPHIC | tm218241d1_ex99-2img023.jpg | GRAPHIC | 208946
31 | GRAPHIC | tm218241d1_ex99-2img024.jpg | GRAPHIC | 234926
32 | GRAPHIC | tm218241d1_ex99-2img025.jpg | GRAPHIC | 306368
33 | GRAPHIC | tm218241d1_ex99-2img026.jpg | GRAPHIC | 227739
34 | GRAPHIC | tm218241d1_ex99-2img027.jpg | GRAPHIC | 126106
35 | GRAPHIC | tm218241d1_ex99-2img028.jpg | GRAPHIC | 89418
36 | GRAPHIC | tm218241d1_ex99-2img029.jpg | GRAPHIC | 143488
| Complete submission text file | 0001104659-21-029613.txt |  | 12922796

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | fold-20210301.xsd | EX-101.SCH | 3217
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | fold-20210301_lab.xml | EX-101.LAB | 34592
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | fold-20210301_pre.xml | EX-101.PRE | 22731
37 | EXTRACTED XBRL INSTANCE DOCUMENT | tm218241d1_8k_htm.xml | XML | 3486

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 21693716
SIC: 2834 Pharmaceutical Preparations